Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Fisher

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Blood|November 24, 1999
Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphomaA S Freedman, D Neuberg, P Mauch, et al.
Bone Marrow Transplantation|October 27, 2004
Routine screening for psychosocial distress following hematopoietic stem cell transplantationS J Lee, F R Loberiza, J H Antin, et al.
Bone Marrow Transplantation|January 25, 2011
(90)Y-ibritumomab tiuxetan followed by reduced-intensity conditioning and allo-SCT in patients with advanced follicular lymphomaK E Abou-Nassar, K E Stevenson, J H Antin, et al.
Bone Marrow Transplantation|July 23, 1998
CD6+ T cell-depleted allogeneic bone marrow transplantation for non-Hodgkin's lymphomaR J Soiffer, A S Freedman, D Neuberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
CD6+ donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donorsR J Soiffer, E Weller, E P Alyea, et al.
Bone Marrow Transplantation|October 19, 2004
Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host diseaseV T Ho, H T Kim, S Li, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 8, 2001
CD20-directed antibody-mediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemiaS P Treon, T B Agus, B Link, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Blood|November 24, 1999
Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphomaA S Freedman, D Neuberg, P Mauch, et al.
Bone Marrow Transplantation|October 27, 2004
Routine screening for psychosocial distress following hematopoietic stem cell transplantationS J Lee, F R Loberiza, J H Antin, et al.
Bone Marrow Transplantation|January 25, 2011
(90)Y-ibritumomab tiuxetan followed by reduced-intensity conditioning and allo-SCT in patients with advanced follicular lymphomaK E Abou-Nassar, K E Stevenson, J H Antin, et al.
Bone Marrow Transplantation|July 23, 1998
CD6+ T cell-depleted allogeneic bone marrow transplantation for non-Hodgkin's lymphomaR J Soiffer, A S Freedman, D Neuberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
CD6+ donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donorsR J Soiffer, E Weller, E P Alyea, et al.
Bone Marrow Transplantation|October 19, 2004
Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host diseaseV T Ho, H T Kim, S Li, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 8, 2001
CD20-directed antibody-mediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemiaS P Treon, T B Agus, B Link, et al.
Pageof 6